このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

Regular HIV Testing Among At-Risk Latino Men

2019年1月31日 更新者:Medical College of Wisconsin
Early HIV diagnosis followed by linkage to treatment soon after HIV infection can reduce mortality and prevent new HIV infections. To obtain the full benefit of early HIV diagnosis, the US Centers for Disease Control and Prevention suggest that high risk groups get tested for HIV regularly, every three to six months. This study will examine the feasibility of a strategy to promote regular HIV testing and HIV risk reduction among Latino men at risk for HIV which, if successful, will help to identify Latino men unaware of their HIV status, benefitting them and the society.

調査の概要

詳細な説明

In the US, the HIV epidemic largely affects clusters of interconnected persons with high HIV prevalence and undiagnosed HIV infections that must be reached to reduce incidence. Latino men who have sex with men (LMSM) are overrepresented in these clusters. Following African Americans, LMSM have the highest HIV incidence rate and are the next most likely to be unaware of their HIV infection. Between 2005 and 2008, nearly one-quarter of the HIV positive LMSM were unaware of the infection.

High HIV prevalence in LMSM networks and lack of strategies to promote regular HIV testing may explain why many LMSM are not benefiting from early diagnosis. Many LMSM face social and legal challenges that hinder their access to healthcare services and outreach. They often have little understanding of HIV treatments, experience discrimination, and hold mistaken assumptions about HIV risk, including beliefs that motivate them to seek sexual partners within their high prevalence in-group as a form of preventing infection.

A social network approach can address the demands of engaging LMSM in regular HIV screening and reduce their collective risk. LMSM often rely on other LMSM who are sources of advice and referrals and who partially shield them from the double jeopardy of being a sexual and ethnic minority. Network interventions can capitalize on these relationships to promote access to resources and foster norms that reward regular testing and encourage collective safety. This project uses social networks to promote regular HIV testing and risk reduction among LMSM. Rather than delivering risk reduction messages and opportunities for HIV testing, the intervention will penetrate networks of LMSM through well positioned members. Unlike strategies that target personal networks or social groups within venues, the intervention will recruit three-ring networks of interconnected LMSM and isolate their ties. Three recruitment rings will help to find less visible LMSM; and isolating their ties will identify who can reach them. In addition to informing and motivating their peers to reduce risk, key network members will be trained to be links to prevention resources, deliver tailored prompts to HIV testing, and support peers' testing behaviors to encourage repetition.

研究の種類

介入

入学 (実際)

107

段階

  • 適用できない

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

18年歳以上 (大人、高齢者)

健康ボランティアの受け入れ

いいえ

受講資格のある性別

男

説明

Inclusion Criteria:

  • self-report as a Latino man who has sex with men (LMSM);
  • living in the Milwaukee area;
  • willing and able to provide consent for participation;

Additional Inclusion Criteria for Social Network Seeds:

  • more than 70% of social network members are LMSM
  • more than 50% of LMSM social network members are at risk for HIV

Exclusion Criteria:

  • Female
  • 17 years of age or younger
  • Unable to provide consent

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:防止
  • 割り当て:ランダム化
  • 介入モデル:並列代入
  • マスキング:なし(オープンラベル)

武器と介入

参加者グループ / アーム
介入・治療
実験的:Social Network
Leaders of social networks will communicate messages endorsing regular HIV testing to network members.
Leaders of social networks will undergo small group training to develop skills to convey information effectively and deliver messages endorsing regular HIV testing to members of their social networks.
All participants will receive HIV counseling and rapid testing following the Wisconsin Department of Health guidelines. Sexually active men who receive a negative test result will be told that they should be HIV-tested every three to six months, unless they have a monogamous HIV negative partner
他の名前:
  • HIV Counseling and Testing
アクティブコンパレータ:Comparison
HIV counseling and testing
All participants will receive HIV counseling and rapid testing following the Wisconsin Department of Health guidelines. Sexually active men who receive a negative test result will be told that they should be HIV-tested every three to six months, unless they have a monogamous HIV negative partner
他の名前:
  • HIV Counseling and Testing

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Frequency of HIV testing
時間枠:Twelve months post intervention
Maximum number of months between two HIV tests
Twelve months post intervention

二次結果の測定

結果測定
メジャーの説明
時間枠
Frequency of HIV testing
時間枠:Twelve months post intervention
Whether the participant received an HIV test every < six months during the 12-month period following study intake
Twelve months post intervention
HIV risk behaviors: Number of unprotected anal intercourse occasions with a non-monogamous partner
時間枠:Twelve months post intervention
Number of unprotected anal intercourse occasions with a non-monogamous partner
Twelve months post intervention
HIV risk behaviors: Number of sexual partners
時間枠:Twelve months post intervention
Number of sexual partners
Twelve months post intervention

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

捜査官

  • 主任研究者:Laura R. Glasman, Ph.D.、Medical College of Wisconsin

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始

2015年6月1日

一次修了 (実際)

2018年6月1日

研究の完了 (実際)

2018年6月1日

試験登録日

最初に提出

2015年4月20日

QC基準を満たした最初の提出物

2015年5月26日

最初の投稿 (見積もり)

2015年5月27日

学習記録の更新

投稿された最後の更新 (実際)

2019年2月4日

QC基準を満たした最後の更新が送信されました

2019年1月31日

最終確認日

2019年1月1日

詳しくは

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する